argenx SE (EBR:ARGX)
Belgium · Delayed Price · Currency is EUR 715.60
0.00 (0.00%)
At close: Dec 29, 2025
argenx SE Market Cap
argenx SE has a market cap or net worth of €43.64 billion as of December 30, 2025. Its market cap has increased by 20.59% in one year.
Market Cap
43.64B
Enterprise Value
40.32B
Revenue
3.14B
Ranking
n/a
PE Ratio
35.95
Stock Price
€715.60
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 122.42M to 43.64B, an increase of 35,543.69%. That is a compound annual growth rate of 66.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 43.79B | 20.91% |
| Dec 31, 2024 | 36.22B | 78.48% |
| Dec 29, 2023 | 20.29B | 5.32% |
| Dec 30, 2022 | 19.27B | 18.28% |
| Dec 31, 2021 | 16.29B | 42.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 44.92B |
| Financière de Tubize | 9.33B |
| Fagron NV | 1.56B |
| Ion Beam Applications | 371.69M |
| Onward Medical | 196.62M |
| Nyxoah | 177.27M |
| Hyloris Pharmaceuticals | 156.80M |
| Sequana Medical NV | 37.03M |